Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Cencora, Inc.

Revenue

Revenue %Chg

Revenue Common Size

Bulk Deliveries to Customer Warehouses

Bulk Deliveries to Customer Warehouses %Chg

Bulk Deliveries to Customer Warehouses Common Size

Total Revenue

Total Revenue %Chg

Total Revenue Common Size

Cost of Goods Sold

Cost of Goods Sold %Chg

Cost of Goods Sold Common Size

Gross Profit

Gross Profit %Chg

Gross Profit Common Size

Distribution, Selling, and Administrative

Distribution, Selling, and Administrative %Chg

Distribution, Selling, and Administrative Common Size

Depreciation

Depreciation %Chg

Depreciation Common Size

Amortization

Amortization %Chg

Amortization Common Size

Warrants

Warrants %Chg

Warrants Common Size

Employee Severance, Litigation, and Other

Employee Severance, Litigation, and Other %Chg

Employee Severance, Litigation, and Other Common Size

Intangible Asset Impairments

Intangible Asset Impairments %Chg

Intangible Asset Impairments Common Size

Pension Settlement

Pension Settlement %Chg

Pension Settlement Common Size

Litigation and Opioid-Related Expenses, Net

Litigation and Opioid-Related Expenses, Net %Chg

Litigation and Opioid-Related Expenses, Net Common Size

Acquisition, Integration, and Restructuring Expenses

Acquisition, Integration, and Restructuring Expenses %Chg

Acquisition, Integration, and Restructuring Expenses Common Size

Acquisition-Related Deal and Integration Expenses

Acquisition-Related Deal and Integration Expenses %Chg

Acquisition-Related Deal and Integration Expenses Common Size

Restructuring and Other Expenses

Restructuring and Other Expenses %Chg

Restructuring and Other Expenses Common Size

Goodwill Impairment

Goodwill Impairment %Chg

Goodwill Impairment Common Size

Impairment of Assets

Impairment of Assets %Chg

Impairment of Assets Common Size

Operating Income

Operating Income %Chg

Operating Income Common Size

Loss on Consolidation of Equity Investments

Loss on Consolidation of Equity Investments %Chg

Loss on Consolidation of Equity Investments Common Size

Other Loss, Net

Other Loss, Net %Chg

Other Loss, Net Common Size

Impairment Charge on Equity Investment

Impairment Charge on Equity Investment %Chg

Impairment Charge on Equity Investment Common Size

Interest Expense, Net

Interest Expense, Net %Chg

Interest Expense, Net Common Size

Loss on Early Retirement of Debt

Loss on Early Retirement of Debt %Chg

Loss on Early Retirement of Debt Common Size

Income Before Income Taxes

Income Before Income Taxes %Chg

Income Before Income Taxes Common Size

Income Tax Expense

Income Tax Expense %Chg

Income Tax Expense Common Size

Income from Continuing Operations Before Cumulative Effect of Change in Accounting

Income from Continuing Operations Before Cumulative Effect of Change in Accounting %Chg

Income from Continuing Operations Before Cumulative Effect of Change in Accounting Common Size

Income from Continuing Operations

Income from Continuing Operations %Chg

Income from Continuing Operations Common Size

Loss from Discontinued Operations, Net of Income Tax Expense

Loss from Discontinued Operations, Net of Income Tax Expense %Chg

Loss from Discontinued Operations, Net of Income Tax Expense Common Size

Cumulative Effect of Change in Accounting, Net of Income Taxes

Cumulative Effect of Change in Accounting, Net of Income Taxes %Chg

Cumulative Effect of Change in Accounting, Net of Income Taxes Common Size

Net Income

Net Income %Chg

Net Income Common Size

Net Loss Attributable to Noncontrolling Interests

Total Revenues

Total Revenues %Chg

Total Revenues Common Size

Cost of Sales

Cost of Sales %Chg

Cost of Sales Common Size

Gross Profit Margin

Gross Profit Margin %Chg

Gross Profit Margin Common Size

Selling, General & Administrative Expenses

Selling, General & Administrative Expenses %Chg

Selling, General & Administrative Expenses Common Size

Depreciation & Amortization Expenses

Depreciation & Amortization Expenses %Chg

Depreciation & Amortization Expenses Common Size

Other Operating Expenses

Other Operating Expenses %Chg

Other Operating Expenses Common Size

Operating Profit

Operating Profit %Chg

Operating Profit Common Size

Operating Margin

Operating Margin %Chg

Operating Margin Common Size

Interest Expense

Interest Expense %Chg

Interest Expense Common Size

Non-Operating Income

Non-Operating Income %Chg

Non-Operating Income Common Size

Total Non-Operating Income

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Adjusted Net Income

Net Revenue

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Income Statement	Sep '25	Sep '24	Sep '23	Sep '22	Sep '21	Sep '20	Sep '19	Sep '18	Sep '17	Sep '16
Total Revenues	321,332.8	293,958.6	262,173.4	238,587	213,988.8	189,893.9	179,589.1	167,939.6	153,143.8	146,849.7
Total Revenues %Chg	9.3%	12.1%	9.9%	11.5%	12.7%	5.7%	6.9%	9.7%	4.3%	8%
Revenue
Cost of Sales	309,854.3	284,048.6	253,213.9	230,290.6	207,045.6	184,702	174,450.8	163,327.3	148,597.8	142,577.1
Cost of Goods Sold
Gross Profit	11,478.5	9,910	8,959.5	8,296.4	6,943.2	5,191.9	5,138.3	4,612.3	4,546	4,272.6
Gross Profit
Gross Profit Margin	3.6%	3.4%	3.4%	3.5%	3.2%	2.7%	2.9%	2.7%	3%	2.9%
Selling, General & Administrative Expenses	6,493.8	5,661.1	5,310	4,849	3,594.3	2,767.2	2,663.5	2,460.3	2,128.7	2,091.2
Distribution, Selling, and Administrative
Depreciation & Amortization Expenses	1,051.1	1,092	963.9	693.9	505.2	391.1	462.4	465.1	397.6	364.7
Depreciation
Amortization
Other Operating Expenses	1,305	981.7	344.9	387.1	489.6	7,169	900.5	243.2	959.3	290.9
Warrants
Employee Severance, Litigation, and Other
Intangible Asset Impairments
Pension Settlement
Litigation and Opioid-Related Expenses, Net
Acquisition, Integration, and Restructuring Expenses
Acquisition-Related Deal and Integration Expenses
Restructuring and Other Expenses
Goodwill Impairment
Impairment of Assets
Operating Profit	2,628.6	2,175.2	2,340.7	2,366.4	2,354.2	-5,135.4	1,111.9	1,443.7	1,060.3	1,525.8
Operating Income
Operating Margin	0.8%	0.7%	0.9%	1%	1.1%	-2.7%	0.6%	0.9%	0.7%	1%
Interest Expense	-291.5	-157	-228.9	-210.7	-174.1	-137.9	-157.8	-174.7	-145.2	-139.9
Interest Expense, Net
Non-Operating Income	78.7	14.3	-49	-27.4	-41.7	-23.8	-13	-40.6	-2.7	-5
Loss on Consolidation of Equity Investments
Other Loss, Net
Impairment Charge on Equity Investment
Loss on Early Retirement of Debt
Total Non-Operating Income	-212.8	-142.7	-278	-238	-215.8	-161.6	-170.7	-215.3	-147.9	-145
Income Before Provision for Income Taxes	2,258.3	2,004	2,160.8	2,183.1	2,221.9	-5,293.8	967.1	1,177.4	917.9	1,390.9
Income Before Income Taxes
Provision for Income Taxes	690.5	484.7	428.3	516.5	677.3	-1,894.3	113	-438.5	553.4	-37
Income Tax Expense
Consolidated Net Income	1,567.8	1,519.3	1,732.6	1,666.5	1,544.6	-3,399.6	854.1	1,615.9	364.5	1,427.9
Income from Continuing Operations Before Cumulative Effect of Change in Accounting
Net Income Attributable to Minority Interests and Other	-13.6	-10.2	12.7	32.3	-4.7	-9.2	1.2	42.5	—	—
Net Loss Attributable to Noncontrolling Interests
Cumulative Effect of Change in Accounting, Net of Income Taxes
Net Income Attributable to Discontinued Operations	—	—	—	—	—	—	—	—	—	—
Loss from Discontinued Operations, Net of Income Tax Expense
Net Income Attributable to Common Shareholders	1,567.8	1,519.3	1,732.6	1,666.5	1,544.6	-3,399.6	854.1	1,615.9	364.5	1,427.9
Net Income
Basic EPS	8	7.6	8.6	8.2	7.5	-16.7	4.1	7.6	1.7	6.7
Diluted EPS	8	7.5	8.5	8	7.4	-16.7	4	7.5	1.6	6.3
Basic Weighted Average Shares Outstanding	0.2	0.2	0.2	208.5	205.9	204.8	210.2	217.9	218.4	212.2
Total Shares Outstanding	193.9	194.9	200.8	206.2	208.1	204.2	204.8	213.2	218	220.1
Diluted Weighted Average Shares Outstanding	0.2	0.2	0.2	211.2	208.5	204.8	211.8	220.3	221.6	226
EBITDA	3,697	3,294.1	3,321.6	3,076.2	2,869	-4,727.3	1,609.4	1,953.8	1,492.7	1,917.9
Effective Tax Rate	30.6%	24.2%	19.8%	23.7%	30.5%	35.8%	11.7%	-37.2%	60.3%	-2.7%